Details of the Drug
General Information of Drug (ID: DM5NBVG)
| Drug Name |
PF-03800130
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | Dual dopamine D2 partial agonist/serotonin reuptake inhibitor (schizophrenia/bipolar disorder), Pfizer | ||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Structure | 3D Structure is Not Available |
![]() |
|||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Bipolar disorder | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | 6A60 | |||||||||||||||||
|
||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||


